European Medicines Agency seeks stakeholders' views on future transparency measures for clinical trials
Br J Clin Pharmacol
.
2023 Aug;89(8):2338-2340.
doi: 10.1111/bcp.15825.
Epub 2023 Jun 22.
Authors
Rosa Gonzalez-Quevedo
1
,
Laura Pioppo
2
,
Juan Garcia Burgos
1
,
Peter Arlett
3
Affiliations
1
Stakeholders and Communication Division, European Medicines Agency, Amsterdam, The Netherlands.
2
Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands.
3
Head of Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands.
PMID:
37345382
DOI:
10.1111/bcp.15825
No abstract available
Publication types
Editorial